Lysosomal Storage Disease Market Therapeutics Review H2 2022
Synopsis
Lysosomal Storage Disease (LSD) is a genetic disorder that causes various types of nervous system disorders such as clinical abnormalities and cellular dysfunction. There are more than 65 categories of LSD. This disease can be classified into Lipid Metabolism Disorder and Glycoprotein Metabolism Disorder. Further Lipid Metabolism Disorder is categorized into Gaucher disease & Fabry disease and Glycoprotein Metabolism Disorder into Pompe disease. LSD develops mainly due to deficiency of lysosomal enzyme in the living body. A person suffering from LSD could experience problems like abnormal growth of bones, delay movement of body, deafness, blindness, dementia, respiratory problems, fatigue/weakness, bone & joint deformity, organ enlargement, lung dysfunction, severe & fatal physical & mental health deterioration.
Lysosomal Storage Disease (LSD) is a genetic disorder that causes various types of nervous system disorders such as clinical abnormalities and cellular dysfunction. There are more than 65 categories of LSD. This disease can be classified into Lipid Metabolism Disorder and Glycoprotein Metabolism Disorder. Further Lipid Metabolism Disorder is categorized into Gaucher disease & Fabry disease and Glycoprotein Metabolism Disorder into Pompe disease. LSD develops mainly due to deficiency of lysosomal enzyme in the living body. A person suffering from LSD could experience problems like abnormal growth of bones, delay movement of body, deafness, blindness, dementia, respiratory problems, fatigue/weakness, bone & joint deformity, organ enlargement, lung dysfunction, severe & fatal physical & mental health deterioration.
The global LSD market is expected to grow with growing
Ashkenazi (Eastern and Western Europe) population, increasing pharmaceutical
R&D spending, growing disposable income, rising healthcare expenditure and
accelerating economic growth.
Click here for
sample report @http://www.wiseguyreports.com/sample-request/3080299-global-lysosomal-storage-disease-lsd-market-fabry-gaucher
Key Highlights
Key trends of this rare disease market includes progressing
drugs under pipeline and increasing preference towards gene therapy. However,
there are some factors which can hinder growth of the market including
stringent regulations and limited access to patent rights.
The report “Global Lysosomal Storage Disease (LSD) Market
(Fabry, Gaucher & Pompe): Industry Analysis & Outlook (2018-2022)” by
Koncept Analytics provides an extensive research and detailed analysis of the
present market along with future outlook.
The report discusses the major growth drivers, key tends
& developments and challenges of the market, covering the global market.
The report profiles the key players of the market including Pfizer Inc., Sanofi
S.A., Shire Plc and Protalix BioTherapeutics, Inc.
Table of Content
1. Market Overview
1.1 Lysosomal Storage Disease
(LSD)
1.2 Classification of LSD
1.3 Symptoms
1.4 Diagnosis
1.5 Treatment
1.6 Upcoming Treatment
2. 2. Global LSD Market Analysis
1.2 Classification of LSD
1.3 Symptoms
1.4 Diagnosis
1.5 Treatment
1.6 Upcoming Treatment
2. 2. Global LSD Market Analysis
2.1 Global LSD Market Forecast by
Value
2.2 Global LSD Market Value by Category
2.3 Global Fabry Disease Market Forecast by Value
2.4 Global Fabry Disease Market Value by Drugs
2.4.1 Global Fabrazyme Sales Value
2.4.2 Global Replagal Sales Value
2.4.3 Global Galafold Sales Value
2.5 Global Gaucher Disease Market Forecast by Value
2.6 Global Gaucher Disease Market Value by Drugs
2.6.1 Global Cerezyme Sales Value
2.6.2 Global Vipriv Sales Value
2.6.3 Global Cerdelga Sales Value
2.7 Global Pompe Disease Market Forecast by Value
2.8 Global Pompe Disease Market Value by Drugs
2.8.1 Global Myozyme Sales Value
3. Market Dynamics
2.2 Global LSD Market Value by Category
2.3 Global Fabry Disease Market Forecast by Value
2.4 Global Fabry Disease Market Value by Drugs
2.4.1 Global Fabrazyme Sales Value
2.4.2 Global Replagal Sales Value
2.4.3 Global Galafold Sales Value
2.5 Global Gaucher Disease Market Forecast by Value
2.6 Global Gaucher Disease Market Value by Drugs
2.6.1 Global Cerezyme Sales Value
2.6.2 Global Vipriv Sales Value
2.6.3 Global Cerdelga Sales Value
2.7 Global Pompe Disease Market Forecast by Value
2.8 Global Pompe Disease Market Value by Drugs
2.8.1 Global Myozyme Sales Value
3. Market Dynamics
3.1 Growth Drivers
3.1.1 Growing Ashkenazi (Eastern and Western Europe) Population
3.1.2 Rising Pharmaceutical R&D Spending
3.1.3 Increasing Disposable Income
3.1.4 Growing Healthcare Expenditure
3.1.5 Accelerating Economic Growth
3.2 Key Trends & Developments
3.2.1 Progressing Drugs under Pipeline
3.2.2 Increasing Preference towards Gene Therapy
3.3 Challenges
3.3.1 Stringent Regulations
3.3.2 Limited Access to Patent Rights
3.1.1 Growing Ashkenazi (Eastern and Western Europe) Population
3.1.2 Rising Pharmaceutical R&D Spending
3.1.3 Increasing Disposable Income
3.1.4 Growing Healthcare Expenditure
3.1.5 Accelerating Economic Growth
3.2 Key Trends & Developments
3.2.1 Progressing Drugs under Pipeline
3.2.2 Increasing Preference towards Gene Therapy
3.3 Challenges
3.3.1 Stringent Regulations
3.3.2 Limited Access to Patent Rights
For Detailed Reading Please visit @https://www.wiseguyreports.com/reports/3080299-global-lysosomal-storage-disease-lsd-market-fabry-gaucher
About Us
Wise Guy
Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium
progressive statistical surveying, market research reports, analysis &
forecast data for industries and governments around the globe. Wise Guy Reports
understand how essential statistical surveying information is for your
organization or association. Therefore, we have associated with the top
publishers and research firms all specialized in specific domains, ensuring you
will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
Ph:
+1-646-845-9349 (US)
Ph: +44 208
133 9349 (UK)
Comments
Post a Comment